A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot study

<p>Abstract</p> <p>Background</p> <p>Osteoarthritis (OA) is a slowly destructive process that may be influenced by a nutritional mineral balance in the body.</p> <p>Methods</p> <p>This small, double blind, placebo controlled pilot study investiga...

Full description

Bibliographic Details
Main Authors: Kuskowski Michael A, Frestedt Joy L, Zenk John L
Format: Article
Language:English
Published: BMC 2009-02-01
Series:Nutrition Journal
Online Access:http://www.nutritionj.com/content/8/1/7
_version_ 1811249880355569664
author Kuskowski Michael A
Frestedt Joy L
Zenk John L
author_facet Kuskowski Michael A
Frestedt Joy L
Zenk John L
author_sort Kuskowski Michael A
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Osteoarthritis (OA) is a slowly destructive process that may be influenced by a nutritional mineral balance in the body.</p> <p>Methods</p> <p>This small, double blind, placebo controlled pilot study investigated the impact of treatment with a natural multi-mineral supplement from seaweed (Aquamin) on 6 minute walking distance (6 MWD), range of motion (ROM), and pain and joint mobility measured by the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in subjects with moderate to severe OA of the knee during gradual withdrawal of non-steroidal anti-inflammatory drugs (NSAIDs) that were being used daily for pain management. Subjects (n = 29) with moderate to severe OA of the knee were randomised to receive either Aquamin (2400 mg/d) or Placebo for up to 12 weeks.</p> <p>Results</p> <p>Of the 29 subjects initially randomized, only 22 subjects proceeded to treatment due to 7 subjects not meeting study selection criteria at baseline. Fourteen subjects completed the study and an ITT analysis (n = 22) of the data showed no significant differences in WOMAC scores however, the data did reveal significant improvements in passive and active extension ROM (0.83° ± 1.54 vs. -1.54° ± 2.43; difference, 5.2° ± 2.2, p = 0.028) and 6 MWD (150 ± 48 ft vs. 12.5 ± 31.5 ft; difference, 136 ± 57 ft, p = 0.03) in the Aquamin group compared to the placebo group; respectively, following a 50% reduction in NSAID use. The treatments were well tolerated and the adverse event profiles were not significantly different between the groups.</p> <p>Conclusion</p> <p>This small preliminary study suggests Aquamin may increase range of motion and walking distances in subjects with OA of the knee and may allow partial withdrawal of NSAIDs over 12 weeks of treatment. Additional research is needed to confirm these preliminary observations.</p> <p>Trial registration</p> <p>NCT00755482</p>
first_indexed 2024-04-12T15:55:13Z
format Article
id doaj.art-8e6f35ae9028435b828cde3f659aac7a
institution Directory Open Access Journal
issn 1475-2891
language English
last_indexed 2024-04-12T15:55:13Z
publishDate 2009-02-01
publisher BMC
record_format Article
series Nutrition Journal
spelling doaj.art-8e6f35ae9028435b828cde3f659aac7a2022-12-22T03:26:23ZengBMCNutrition Journal1475-28912009-02-0181710.1186/1475-2891-8-7A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot studyKuskowski Michael AFrestedt Joy LZenk John L<p>Abstract</p> <p>Background</p> <p>Osteoarthritis (OA) is a slowly destructive process that may be influenced by a nutritional mineral balance in the body.</p> <p>Methods</p> <p>This small, double blind, placebo controlled pilot study investigated the impact of treatment with a natural multi-mineral supplement from seaweed (Aquamin) on 6 minute walking distance (6 MWD), range of motion (ROM), and pain and joint mobility measured by the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in subjects with moderate to severe OA of the knee during gradual withdrawal of non-steroidal anti-inflammatory drugs (NSAIDs) that were being used daily for pain management. Subjects (n = 29) with moderate to severe OA of the knee were randomised to receive either Aquamin (2400 mg/d) or Placebo for up to 12 weeks.</p> <p>Results</p> <p>Of the 29 subjects initially randomized, only 22 subjects proceeded to treatment due to 7 subjects not meeting study selection criteria at baseline. Fourteen subjects completed the study and an ITT analysis (n = 22) of the data showed no significant differences in WOMAC scores however, the data did reveal significant improvements in passive and active extension ROM (0.83° ± 1.54 vs. -1.54° ± 2.43; difference, 5.2° ± 2.2, p = 0.028) and 6 MWD (150 ± 48 ft vs. 12.5 ± 31.5 ft; difference, 136 ± 57 ft, p = 0.03) in the Aquamin group compared to the placebo group; respectively, following a 50% reduction in NSAID use. The treatments were well tolerated and the adverse event profiles were not significantly different between the groups.</p> <p>Conclusion</p> <p>This small preliminary study suggests Aquamin may increase range of motion and walking distances in subjects with OA of the knee and may allow partial withdrawal of NSAIDs over 12 weeks of treatment. Additional research is needed to confirm these preliminary observations.</p> <p>Trial registration</p> <p>NCT00755482</p>http://www.nutritionj.com/content/8/1/7
spellingShingle Kuskowski Michael A
Frestedt Joy L
Zenk John L
A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot study
Nutrition Journal
title A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot study
title_full A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot study
title_fullStr A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot study
title_full_unstemmed A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot study
title_short A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: A randomised, placebo controlled pilot study
title_sort natural seaweed derived mineral supplement aquamin f for knee osteoarthritis a randomised placebo controlled pilot study
url http://www.nutritionj.com/content/8/1/7
work_keys_str_mv AT kuskowskimichaela anaturalseaweedderivedmineralsupplementaquaminfforkneeosteoarthritisarandomisedplacebocontrolledpilotstudy
AT frestedtjoyl anaturalseaweedderivedmineralsupplementaquaminfforkneeosteoarthritisarandomisedplacebocontrolledpilotstudy
AT zenkjohnl anaturalseaweedderivedmineralsupplementaquaminfforkneeosteoarthritisarandomisedplacebocontrolledpilotstudy
AT kuskowskimichaela naturalseaweedderivedmineralsupplementaquaminfforkneeosteoarthritisarandomisedplacebocontrolledpilotstudy
AT frestedtjoyl naturalseaweedderivedmineralsupplementaquaminfforkneeosteoarthritisarandomisedplacebocontrolledpilotstudy
AT zenkjohnl naturalseaweedderivedmineralsupplementaquaminfforkneeosteoarthritisarandomisedplacebocontrolledpilotstudy